Mitchell E. Horwitz, MD, discussed how omidubicel and other advances in allogeneic transplantation have affected different hematologic oncology populations.
Mitchell E. Horwitz, MD
Advertisement
Articles by Mitchell E. Horwitz, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
VT-EBV-N Yields Durable Disease-Free Survival in Pretreated ENKTL
2
Tisa-Cel Yields Enduring Remissions in Younger High-Risk B-ALL Population
3
Anbenitamab Regimen Meets Phase 3 End Points in HER2+ Breast Cancer
4
Investigators Halt Phase 3 Trial of Sacituzumab Govitecan Combo in NSCLC
5